Naloxon B. Braun Stungulyf/innrennslislyf, lausn 0,4 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

naloxon b. braun stungulyf/innrennslislyf, lausn 0,4 mg/ml

b.braun melsungen ag* - naloxonum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,4 mg/ml

Gentamicin B. Braun Innrennslislyf, lausn 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

gentamicin b. braun innrennslislyf, lausn 1 mg/ml

b. braun melsungen ag - gentamicinum súlfat - innrennslislyf, lausn - 1 mg/ml

Gentamicin B. Braun Innrennslislyf, lausn 3 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

gentamicin b. braun innrennslislyf, lausn 3 mg/ml

b. braun melsungen ag - gentamicinum súlfat - innrennslislyf, lausn - 3 mg/ml

Elonva Evrópusambandið - íslenska - EMA (European Medicines Agency)

elonva

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - hormón kynlíf og stillum kynfæri - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).